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Abstract
Listeriosis is a rare but severe disease, mainly caused by Listeria monocytogenes. This
study shows the results of the laboratory-based surveillance of Listeriosis in Belgium over
the period 1985–2014. Besides the incidence and some demographic data we present also
more detailed microbiological and molecular characteristics of human strains isolated since
2000. The strains from the latter period were compared to food and animal strains from the
same period. Our study shows that different food matrices were commonly contaminated
with L. monocytogenes presenting the same PFGE profile as in patient’s isolates. Since
1985, we observed a significant decrease in incidence of the Materno-Neonatal cases
(from 0.15 to 0.04 cases /100,000 inhabitants-year), which is probably to be attributed to
active prevention campaigns targeting pregnant women. Despite the strengthening of dif-
ferent control measures by the food industry, the incidence of non-Materno-Neonatal listeri-
osis increased in Belgium (from 0.3 to 0.7 cases /100,000 inhabitants-year), probably due
to the rise of highly susceptible patients in an aging population. This significant increase
found in non-Materno-Neonatal cases (slope coefficient 7.42%/year, P<0.0001) can be
attributed to significant increase in incidence of isolates belonging to serovars 1/2a (n =
393, slope coefficient 6.62%/year, P<0.0001). Although resistance to antimicrobials is rare
among L. monocytogenes isolates, a trend to increasing MIC values is evident with chlor-
amphenicol, amoxicillin, tetracycline and ciprofloxacin. We show that fluoroquinolone resis-
tance is not linked to chromosomal mutations, but caused by a variety of efflux pumps. Our
study also shows that huge majority of known underlying pathologies (426 out of 785
cases) were cancers (185/426, 43.1%) and haematological malignancies (75/185, 40.5%).
Moreover the risk population is susceptible to low levels of contamination in food stressing
the need of prevention campaigns specifically targeting these persons.
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Introduction
Listeria monocytogenes is an ubiquitous bacterium, able to survive and replicate in harsh con-
ditions including dry environments, low temperatures and a wide pH range. This Gram-posi-
tive pathogen can infect various animals like mammals, birds, fish and crustaceans, which
can either become asymptomatic carriers or develop a clinical disease. Human are most likely
to be infected through consumption of contaminated foods and/or feedstuffs [1]. Once
ingested, L.monocytogenes can cause severe infections such as septicaemia,meningitis, or
parenchymal brain infections with a mortality reaching up to 30% [2, 3]. The majority of the
listeriosis cases occur in elderly, immunosuppressed patients, pregnant women and neonates.
Although the symptoms of listeriosis in pregnant women are often mild, there is a high risk
of trans-placental transmission causing miscarriage, congenital defects, preterm birth and
even stillbirth [4, 5, 6].
Current chemotherapy of listeriosis is based on the synergic action of ampicillin/penicillin
and aminoglycosides, while trimethoprim is applied in case of intolerance to β-lactams [6, 7].
This standard treatment regime of Listeria has remained unchanged for decades due to the
very low resistance rates against these first-line drugs (e.g., [8, 9, 10]. Indeed, recent European
studies identified less than 2% of human L.monocytogenes isolates resistant for at least one
antibiotic, mainly tetracycline [11, 12]. Interestingly, in contrast to β-lactam and aminoglyco-
sides antibiotics which greatly lose their effectiveness in the intracellular environment where L.
monocytogenes thrives, fluoroquinolones (FQs) remain bactericidal and can achieve a 99.9%
bacterial killing within 24 hours [13]. Despite successful use of levofloxacin in acute bacterial
meningitis in humans [14] and moxifloxacin in mice [15], FQs are not recommended in the
treatment of listeriosis given the increased risk of side-effects in patients with impairments of
the central nervous system [16]. Recently, rising non-susceptibility against fluoroquinolones
has been reported in France [11] and Switzerland [12] which might have been caused by the
extensive use of FQ for the treatment of multiple infections [17].
Laboratory surveillance of L.monocytogenes is based on the classical characterization of
the isolate, using biochemistry testing and serotyping. Among the 13 described serotypes of
L.monocytogenes, 1/2a, 1/2b and 4b are causing 95% of the human infections [3]. Serotype
4b is responsible for 33–50% of the sporadic human cases worldwide and for the majority of
foodborne outbreaks reported in Europe and North America since 1980s [18]. To date,
MLST and PFGE are still considered as the gold standard for the molecular subtyping of this
pathogen [19, 20]. Logically, they will be replaced by whole-genome sequencing in the fore-
seeable future [21].
Like in the majority of European countries, Belgian surveillance of listeriosis is based on
two complementary approaches: the mandatory notification of cases and the laboratory sur-
veillance of the strains voluntary submitted to the National Reference Center (NRC) [22].
Therefore, the BelgianNRC holds a unique position to study long-term trends (1985–2015) in
listeriosis, and to describe the major characteristics of the 863 cases recorded between 2000
and 2014.
Materials and Methods
Definitions
A listeriosis case is considered as materno-neonatal (MN) when it involves a pregnant woman,
a miscarriage, a stillbirth or a new-born infant under 28 days old. When L.monocytogenes is
isolated from the pregnant woman and her newborn child, it is counted as a single case. If a
case fits none of these parameters, it is considered as non-materno-neonatal (n-MN).
Listeriosis in Belgium during the Last Decades
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Bacterial isolates
In Belgium, human strains of Listeria monocytogenes were isolated in clinical laboratories mostly
from blood (75.8%), CSF (13.4%), (in rare cases) ascites fluid (1.6%) and perinatal samples
(3.6%). In some rare cases the NRC received 2 strains from one patient, one isolated from blood
and the other one from CSF. The NRC performed the analysis on both isolates. These cases were
then grouped as “meningitis+ sepsis”. The strains were sent on a voluntary basis to the National
Reference Center for Listeria for confirmation of the identification and typing. The BelgianNRC
exists since 1966 and the Listeria isolates are collected at least since 1980 in the same way.
Furthermore, the NRC receives also a wide variety of food isolates from the National Refer-
ence Laboratory for Listeria monocytogenes obtained from food intoxication investigations and
during foodmonitoring programs conducted by the Federal Agency for the safety of the Food
Chain. The control of Listeria monocytogenes in the food chain is based on self-checking sys-
tems in the food industry, an annual laboratory monitoring of specified food products by the
Federal Agency for the Safety of the Food Chain and on foodborne outbreak investigations.
After a non-compliant laboratory result, the food plant is inspected and the product is with-
drawn from the market.
Animal isolates were obtained from clinical cases in various animal species.
In the period 1985–2014, a total of 1,436 human Listeria monocytogenes isolates were col-
lected in a Belgian surveillance program. Since 2000, by using an epidemiological inquiry form,
the postal code and age of the patient, as well as information on the clinical disease and the pos-
sible underlying pathology was more systematically available (In the very rare cases with multi-
ple co-morbiditiesmentioned on the inquiry form, the one with the presumably most acute
character was withheld).
Strain identificationwas carried out with API-Listeria biochemicalmicrogallery and hae-
molysis test (bioMérieux, France). All isolates were serotyped according to a standard protocol
[23] using a commercial agglutination test (Denka Seiken, Tokyo, Japan) for somatic (O) and
flagellar (H) antigens.
Antimicrobial testing and analysis of genetic determinants of FQR
Since 2000, 737 out of 863 received isolates were tested for antimicrobial susceptibility. For all
isolates, the minimal inhibitory concentration (MIC) of a panel of 10 antibiotics (ampicillin,
amoxicillin, gentamicin, ciprofloxacin, streptomycin, chloramphenicol, tetracycline, vancomy-
cin, trimethoprim/sulphamethoxazole and erythromycin) was determined on Mueller-Hinton
agar plates using commercial E-test strips (BioMérieux). To study the involvement of efflux
pumps in fluoroquinolone resistance, the assay for ciprofloxacin, norfloxacin and moxifloxacin
was repeated with either thioridazine (12.5 mg/L), chlorpromazine (25 mg/L), verapamil (200
mg/L) or reserpine (20 mg/L) added to the growth medium. If available, EUCAST clinical
breakpoints were used for interpretation. For all other antibiotics, we used previously described
breakpoints [12] (S1 Table).
Genomic DNA from isolates expressing reduced susceptibility to ciprofloxacin (MIC>1μg/
ml) was extracted using Bacterial GenomicMiniprep Kit (Sigma), and the sequences of quino-
lone-resistance determining regions (QRDR) of gyrA, gyrB, parC and parE were determined as
described elsewhere [24]. All sequences were screened for SNPs in comparison to correspond-
ing regions of FQ-sensitive clinical strains using Clustal omega [25].
Molecular typing analyses
To investigate whether trends in annual incidence were due to sporadic cases or clustered cases
Pulsed-FieldGel Electrophoresis was performed on all cultivable human isolates (N = 338) and
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a random selection of food isolates in conjunction with the monitoring programme of the Bel-
gian Federal Agency for the Safety of the Food Chain (N = 242) and animal isolates (N = 22)
received since 2009. PFGE analysis was done following the PulseNet protocol after DNA diges-
tion with the ApaI (ThermoFisher Scientific) or AscI (ThermoFisher Scientific) enzymes.
Banding pattern analysis was performedwith BioNumerics (Applied Math). A cluster analysis
on the fingerprints obtained by one enzyme was made by means of a similarity matrix calcula-
tion using the Dice coefficient followed by a dendrogram construction using the unweighted
pair group method using averages (UPGMA) as algorithmwith optimization and tolerance set
to 1%. A concatenated analysis of both similarity matrixes of bothApaI and AscI fingerprints
can be carried out resulting in a cluster analysis characterizing all strains on the average simi-
larity using both methods, with a UPGMA tree as result. Isolates with indistinguishableApaI
and AscI combined macrorestriction profiles were defined as the same pulsovar. In Belgium,
there is no systematic investigation of routine cases. An epidemiological investigation is only
carried out in the case of outbreak. Consequently, no epidemiological field work was performed
during the surveillanceperiod presented in the manuscript to confirm observed clusters based
on the detection of identical PFGE pulsovars.
Multi-locus sequence typing (MLST) was performed on all cultivable human isolates
(N = 338) received since 2009 according to the method describedby Ragon et al [26] which is
based on allelic analysis of 7 housekeeping genes. Isolates were assigned to clonal complexes
according to the Listeria MLST website (http://www.pasteur.fr/recherche/genopole/PF8/mlst/
Lmono.html).
Data analysis and statistical tests
Annual incidence rates are calculated based on population data obtained from http://statbel.
fgov.be/nl/statistieken/cijfers/bevolking/structuur/leeftijdgeslacht/belgie/
The statistical variation of the number of cases (annual global incidence) was estimated by a
generalized linear model according to the Poisson regression. For this purpose, the Stat10 soft-
ware was used (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX,
77845 USA). Time series analysis for evaluation of seasonal variations was performed by calcu-
lating a centred moving average (CMA) on the trimestral frequency of Listeria monocytogenes
[27]. Furthermore, a multiple linear regression for both seasonal variation and chronological
trend was calculated for this period by using Excel, Microsoft Office 2010. To evaluate the effect
of age and gender on Listeria risk, the number of cases were grouped by age category for each
gender. The association strength within each stratum of age was measured by the incidence
rate ratio (IRR) with exact Fisher test for statistical significance. The difference in global risk of
infection for gender was estimated by the Mantel-Haenszel Chi2 test.
Results
Epidemiological characteristics in human listeriosis
Although it is not mandatory, the NRC Listeria receives almost 90% of the human L.monocyto-
genes isolates in Belgium. In the period 1985–2014, a total of 1,436 human Listeria monocyto-
genes isolates were collected in a Belgian surveillanceprogram. Since 1987, the national annual
incidence of listeriosis gradually increased significantly from 0.3 to 0.7 cases /100,000 inhabi-
tants-year (slope coefficient 2.07%/year, P<0.0001; Fig 1). This increase is mainly due to the
significant raise of annual incidence of n-MN listeriosis, from 0.2 to 0.7 cases/100,000 inhabi-
tants-year (slope coefficient 3.71%/year, P<0.0001). Among the 785 n-MN forms reported
since 2000, 72.2% were found in patients older than 60 years and 55.5% (436 cases on 785)
were male (sex ratio of 1.3). The highest annual incidence was found in the population older
Listeriosis in Belgium during the Last Decades
PLOS ONE | DOI:10.1371/journal.pone.0164283 October 10, 2016 4 / 16
than 70 years and in male older than 90 years (Fig 2). Over the same period,we noticed a sig-
nificant decrease of annual incidence of the MN from 0.15 to 0.04 (slope coefficient -5.73%/
year, P<0.0001). Since 2000, the annual incidence of MN form remained stable; 78 MN forms
were reported comprising 16 foetal deaths or neonates deceased in the first 48 hours after
birth.
Fig 1. Annual incidence (/100000 inhabitants) of listeriosis, Materno-Neonatal (MN) listeriosis and non-Materno-Neonatal listeriosis
in Belgium between 1985 and 2014.
doi:10.1371/journal.pone.0164283.g001
Fig 2. Mean incidence of non-Materno-Neonatal listeriosis per age and gender between 2000 and 2014 in Belgium.
doi:10.1371/journal.pone.0164283.g002
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Detailed analysis showed an elevated association of listeriosis with increasing age in both
genders. In females, the risk almost doubles in each 10-year-age category, from less than then
8/107 person-years (<39y) to greater than 80/107 person-years (>80y). This effect was even
more pronounced in males, with a statistically significant difference when compared to females
from persons aged 60-and over (P<0.004). Moreover, when adjusted for age, the global risk of
infection in males was 1.5 times greater than in females (P<0.001).
Six hundred twenty five (79.6%) patients on 785 n-MN listeriosis cases presented a septicae-
mia, 57 (7.3%) patients developed a meningitis and 55 (7.0%) had concomitant L.monocyto-
genes bloodstream infection and meningitis. Fourty five patients (5.7%) presented other
symptoms like peritonitis, wound or prosthetic infections etc. . . Only 3 cases of the cutaneous
form of listeriosis were observed,which were contracted through a professional exposure (vet-
erinarians and farmers).
An underlying pathology was known for 426 out of 785 cases (54.3%). The huge majority of
cases concerned cancers (185/426, 43.1%) and haematological malignancies (75/185, 40.5%)
(Table 1).
Concerning the seasonal trends, with the exception of the April 2011 outbreak, an increase
of the sporadic cases was observed almost each year between June to November. A residual
error analysis (Tarone’s test for homogeneity with Chi2 = 14.947 with df = 10 and P = 0.134)
showed that the impact of the higher frequency in summer and autumn, in this 15-year period,
is to be considered as a continuous phenomenon rather than as a coincidence.
Strains analysis
During the period 2000–2014, 45,5% of the 863 Listeria monocytogenes isolated from patient
were serotyped as 1/2a (n = 393), which is the dominant serotype, followed by 4b (38,3%,
n = 331), 1/2b (11,5%, n = 99) and 1/2c (2,4%, n = 21). Other serotypes like 3a, 3b, 4a, 4c, 4d
and 4e were rarely identified (1–5 times during this 15 years period)(Fig 3).
Interestingly, clear difference emerged between the two main serotypes. The significant
overall increase in annual incidence of isolates belonging to serovars 1/2a (n = 393, slope coeffi-
cient 6.62%/Year, P<0.0001) can be attributed to their significant increase found in n-MN
cases (slope coefficient 7.42%/Year, P<0.0001) (Fig 3). The discrete decrease in annual inci-
dence observed in the MN cases of serovar 1/2a was not significant.We identified 77 pulsovars
Table 1. Number of n-MN listeriosis cases per associated pathologies and serotypes.
Total 1/2a 4b 1/2b 1/2c 3a 3c 4a 4c 4d 4e sp.
Cancer 185 92 60 19 9 2 1 1 1 0
Digestive diseases 52 23 16 13 0
Respiratory diseases 35 18 12 1 2 1 1 0
Chronic kidney diseases 33 18 11 4 0
Immunosuppression 29 17 6 3 2 1
Heart diseases 23 11 5 6 1
Iatrogenic immunosuppression 20 9 11 0
Alcoholism 20 12 5 2 1 0
Transplantation 14 6 5 2 1 0
Surgery 12 4 7 1 0
Autoimmune Diseases 2 1 1 0
infection/wound 1 1 0
No indication 359 158 146 41 6 2 1 1 1 1 2
Total 785 370 285 92 20 5 1 2 1 2 3 4
doi:10.1371/journal.pone.0164283.t001
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and 33 ST grouped in 22 clonal complexes (Figs 4a and 5). The number of sporadic 1/2a cases
(unique pulsovars) remained stable, whereas the proportion of cases related to clusters corre-
sponded with the fluctuating annual incidence during this 6-year period (Fig 3). Only one pul-
sovar belonging to CC8 was observed every year and often observed at high frequency (1–8
cases/year).
As shown in fig 3, the total annual incidence for serovar 4b (n = 145) isolates did not change
significantly over time. However, this seems due to a significant decrease in the MN cases
(slope coefficient -7.71%/year, P<0.0001), compensating the significant increase in n-MN
cases (slope coefficient 1.90%/year, P<0.0001) (data not shown). We identified 58 pulsovars
and 12 ST grouped in 8 clonal complexes (of which 72% (104/145) belonged to CC1, 4 or 6
defined as hypervirulent by Maury et al. (2016))[28] (Figs 4b and 5); The proportion of 4b
cases related to clusters increased independent from the annual incidence (Table 2).
PFGE analysis on 175 serovar 1/2a food isolates of the same period showed 78 different pul-
sovars of which 22 pulsovars were identical to human pulsovars (17 out of 22 observedwithin
a 1-year timeframe). PFGE analysis on 67 serovar 4b food isolates of the same period showed
40 different pulsovars of which 17 pulsovars were identical to human pulsovars (15 out of 17
observedwithin a 1-year timeframe).
Among the animal isolates, 3 (out of 6) and 12 (out of 16) pulsovars were identical to
human pulsovars for serovars 1/2a and 4b, respectively.
Antimicrobial resistance
The MIC distribution of the 10 tested antimicrobials are displayed in S1 Table, and graphically
summarized in Fig 6. In 737 tested strains, phenotypic resistance to tetracycline (n = 2), strep-
tomycin (n = 1), ampicillin (n = 1), chloramphenicol (n = 4), trimethoprim/suphamethoxazole
(n = 1) and ciprofloxacin (n = 24) was detected. Only monoresistant strains were encountered,
accounting for 4.5% of all isolates. Linear trend analyses (Mantel-Haenszel test) of the MIC50
values showed that the sensitivity to antimicrobials remained unchanged for ampicillin,
Fig 3. Annual incidence (/100000 inhabitants) of listeriosis caused by serovar 4b and 1/2a, and other serotypes in Belgium between 1985 and
2014.
doi:10.1371/journal.pone.0164283.g003
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Fig 4. Minimal spanning tree of 7-gene MLST of L. monocytogenes isolates of serovar 1/2a (a) and 4b
(b) isolated in 2009–2014. Each node represents a different 7-gene MLST profile with frequency-dependent
size. Node colour represents isolation year. Branch thickness indicates number of different loci in the 7-gene
MLST profile of the connected nodes.
doi:10.1371/journal.pone.0164283.g004
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vancomycin erythromycin and trimethoprim/suphamethoxazole between 2000 and 2014 or
declined in case of gentamicin (P<0.0001) and streptomycin (P = 0.0005). However, a trend to
increasingMIC values is evident with chloramphenicol (0.0005), amoxicillin (P<0.0001), tetra-
cycline (P<0.0001) and ciprofloxacin (P<0.0001) (Fig 6).
Given the extraordinary potency of moxifloxacin in treatment of listeriosis, we decided to
perform a molecular characterization of strains displaying fluoroquinolone resistance (S2
Table). Four main observationswere made. Firstly, the four L.monocytogenes strains resistant
to either ciprofloxacin and/or norfloxacin (MIC> 4μg/ml) remained susceptible to moxifloxa-
cin (MIC< 0.5μg/ml). Secondly, this resistance was not caused by genomic target mutations,
as the quinolone-resistance determining regions (QRDRs) of GyrA, GyrB, ParC and ParE in
Fig 5. Distribution of Clonal Complexes (CC) of human L. monocytogenes isolates of 2009–2014. Rare CC observed less than 5 times are
grouped (Other).
doi:10.1371/journal.pone.0164283.g005
Table 2. Pulsovar diversity and cluster distribution of Listeria monocytogenes strains isolated in 2009–2014 for strains belonging to serovars 1/
2a and 4b*.
2009 2010 2011 2012 2013 2014
1/2a
# isolates analysed 35 16 37 18 36 51
# different pulsovar 13 0 19 0 16 28
# sporadic cases 22 16 18 18 20 23
# cases in cluster 22 15 19 15 20 27
proportion in cluster 37.1 0.0 51.4 0.0 44.4 54.9
# cluster 2 0 3 0 4 7
Range of frequency each pulsovar; min-max 1–9 1–2 1–12 1–2 1–7 1–6
4b
# isolates analysed 18 19 34 27 22 25
# different pulsovar 0 0 3 6 3 6
# sporadic cases 0.0 0.0 8.8 22.2 13.6 24.0
# cases in cluster 18 19 31 21 19 19
proportion in cluster 17 18 30 20 16 18
# cluster 0 0 1 2 1 2
Range of frequency each pulsovar; min-max 1–2 1–2 1–3 1–3 1–3 1–3
*A cluster was defined as3 cases with identical pulsotypes within 14 weeks.
doi:10.1371/journal.pone.0164283.t002
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Fig 6. Yearly evolution of antimicrobial resistance in Belgian L. monocytogenes isolates (2000–2014). MIC50 and
MIC90 values are indicated in black and grey, respectively. When in the figure range, clinical breakpoints are shown as
broken lines, and zones of intermediate resistance as grey blocks.
doi:10.1371/journal.pone.0164283.g006
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these strains were indistinguishable from corresponding regions in 13 other isolates, fully sensi-
tive to ciprofloxacin (S2 Table). Thirdly, and in contrast to a previous study performed in
France (Morgan 2010), the efflux pump inhibitor (EPI) reserpine was not able to cause a signif-
icant decrease in ciprofloxacin resistance in all cases. Indeed, while strains 2007–175 and
2011–113 displayed3-fold reductions in MICCIP in the presence of reserpine,MICCIP of
strain 2005–13 decreased from>32 μg/ml to only 12μg/ml, and 2006–231 was completely
insensitive to reserpine (S2 Table). Fourthly, norfloxacin seems to be a less suitable substrate
for the reserpine-sensitive pumps, as a maximum of 2-fold MICNOR reductions were observed.
Finally, we repeated the MIC analyses while including ½MIC concentrations of three other
EPI. We observed strong reductions in MICCIP/NOR values, but especially addition of verapamil
led reversion of the resistance phenotype in all tested cases. These results strongly suggested
the involvement of other, yet uncharacterized efflux pumps in fluoroquinolone resistance in
isolates 2005–13 and 2006–231.
Discussion
This study provides an overviewof listeriosis trends in humans in Belgiumduring the last
thirty years. This extensive surveillance study shows marked changes in the distribution of MN
cases and n-Mn cases in this country. As reported in both other European countries and the
US [4, 29, 30, 31, 32], the annual incidence of MN listeriosis cases significantly decreased from
1985 until now. This can probably be attributed to (numerous) prevention campaigns targeting
pregnant women [4, 33]. Nevertheless, an active surveillance remains crucial especially in a
periodwhere immigration and /or economicmigration will confront us with a vulnerable pop-
ulation. As shown in the study of Mook [34] an increase in the number of MN cases was noted
in London affecting particularly pregnant women belonging to ethnic minorities which did not
receive the food safety messages emitted by the authorities. In Belgium, the ethnic origin of the
patient was not always mentioned on the inquiry form.
At the same time, our study showed that the increase of annual incidence of the n-MN liste-
riosis is due to the emergence of the serotype 1/2a. This increase was also recently reported in a
Danish study covering the last decade [35]. These isolates remain broadly susceptible to antibi-
otics, although the MIC90 of ciprofloxacin has recently crossed the intermediate breakpoint of
1 μg/ml. Our results show that a variety of efflux pumps are responsible for this phenotype,
expanding previous studies which solely linked the reserpine-dependent FepA and Lde pumps
to ciprofloxacin resistance [17, 36]. The identification of underlyingmechanisms will be subject
on a follow-up study.
In current treatment for bacterialmeningitis in adults and children, ampicillin is added to
3rd generation cephalosporin to cover Listeria monocytogenes. Given the low rates of resis-
tances, there is no immediate need to change this regimen [8, 9, 10].
Within serovar 1/2a, the most frequent human pulsovar-ST8 type was the only type
observed every year. This type shows relatedness with CC8 isolates responsible for outbreaks in
Canada, Denmark, Switzerland and Germany, and is known to persist in food processing envi-
ronments [35, 37, 38, 39]. Better adaptation to growth under stressful conditions (e.g. acidity,
NaCl concentrations) and higher biofilm formation capacity may explain their persistence in
food production environments [40, 41]. However, our results show that only persistence is
insufficient to cause high numbers of human listeriosis cases. The frequent human pulsovar-
ST8 type was observed in food during the study period but at low frequency. On the other
hand, the most frequent and persistent pulsovars observed in food tended to cause few human
cases.Whether this can be explained by less-than-wild-type virulence potential of these strains
needs to be further investigated.
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Molecular subtyping of isolates showed a higher discriminatory power of PFGE over MLST.
This difference was most evident in serovar 4b where nearly four times more pulsovars than
sequence types were detected (Figs 4 and 5). This can be explained by the previously reported
higher recombination rate of lineage II [42], differences in gene content, mobile elements and
positive selection [43]. In contrast to some reports from other European countries where the
increasing annual incidence resulted from a rise in sporadic cases [44, 45], our results show
that cases related to several small clusters of identical pulsovars are responsible for the observed
increase in Belgium.Our study has also shown that different food products were contaminated
with L.monocytogenes presenting the same pulsovar as human isolates. Even if a link can be
assumed between some food products and a patient, it still remains complicated to establish a
convincing circumscription of listeriosis clusters and diffuse outbreaks due to the relative long
incubation period rendering it nearly impossible to establish a clear epidemiological link
between the case and a common food vehicle [46]. Molecular subtyping by higher resolution
techniques as Whole Genome Sequencing (WGS) might help in further investigating clusters
and possible food links as has been shown in recent studies [39, 47]. However, results from Sta-
siewicz et al [48] showed that not necessarily all challenges associated with current subtyping
techniques will be overcome by WGS and that epidemiological data will remain important.
The finding that the annual incidence of the n-MN listeriosis is higher among males over 60
years of age, was also observed in other studies [49]. A possible explanation can be found in the
number of predisposing factors such as underlying diseases found to be more prevalent in
males than in females [50]. Furthermore, as shown by Swaminathan [49], this increase in the
annual incidence is probably largely due to the presence of highly susceptible group of patients
(Cancers, immunosuppressive treatments, transplantation. . ..) in an aging European popula-
tion. These observations, combined with the success of the prevention campaigns targeting
pregnant women, support the idea that similar campaigns directed to other risk groups are
required to invert this trend. Another contributing factor is that the risk group (elderly, immu-
nosuppressed patients. . .) seems susceptible to low levels of contamination. Indeed, during a
Belgian outbreak in 2011 [46] affecting 12 persons and responsible for the death of 4 of them,
the level of contamination of the hard cheese was under 100 cfu Listeria monocytogenes/gr.
This product was thus still conform to the EC regulation. An adaptation of the EC norm (e.g.
with the inclusion of food destined for patients at risk) should also be taken in consideration.
In the United Kingdom, it was already recommended that food served to hospital patients
should be free of L.monocytogenes [51].
In conclusion, despite the strengthening of different control measures by the food industry,
the incidence of listeriosis and more specifically of n-MN listeriosis increased in Belgium as
well as in other European countries during the last decade. This is probably due to the rise of
highly susceptible patients (aging population developing associated diseases increasing their
susceptibility to this pathogen). This issue merits a further in depth analysis. Furthermore
other parameters such as the use of anti-TNF alfa, anti-acids and corticoids are known to have
an impact on the increase of listeriosis [52]. Moreover, the risk population is susceptible to low
levels of contamination of the food stressing the need of prevention campaign specifically tar-
geting the persons belonging to this population.
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